Lilly expands specialty portfolio in India

New Delhi: US firm Eli Lilly is deepening its specialty portfolio in India across cardio metabolic health, oncology, neurology and immunology, with the launch of its Alzheimer’s therapy. The company has strategic partnerships with domestic drugmakers Lupin and Cipla in diabetes and metabolic care, and also markets the blockbuster weight-loss therapy Mounjaro in India.The treatment,…

Read More

With better than Rajdhani experience & 160 kmph speed, can Vande Bharat sleeper trains be a game-changer for Indian Railways?

Vande Bharat sleeper train Premium trains – better than Rajdhani and Tejas Express – and offering enhanced passenger comforts and importantly higher average speeds will in the coming years be the new reality for overnight travel on Indian Railways – courtesy the Vande Bharat sleeper train project. Over 250 new trains are in the pipeline…

Read More

RBI eases outward remittance norms, removes prior approval requirement for non-bank entities

The Reserve Bank of India (RBI) on Wednesday removed the requirement for non-bank entities to obtain prior approval for tie-up arrangements to facilitate outward remittance services through banks in India, PTI reported.The central bank also issued a revised operating framework for facilitating outward remittance services by non-bank entities through Authorised Dealer (AD) Category-I banks.“On a…

Read More